NEW YORK, July 6, 2015 /PRNewswire/ -- Report
Details
Treating diabetes – benefit your influence by finding new R&D
trends and sales prospects
Discover the future of antidiabetic medicines. For those
treatments, you will receive diabetes market size and revenue
projections. You will learn the future potential by exploring
research and development pipelines. And you will be able to assess
results, trends, technologies, therapies and future business
opportunities.
Visiongain's updated report forecasts those revenues to 2025 at
overall world market, submarket, product and national level. You
can stay ahead with clear market data for treating human diabetes,
finding commercial outlooks to benefit your research, analysis and
authority.
See what's possible for treating diabetes mellitus. Read on, then,
to explore treatment of those metabolic diseases, also finding
those medicines' predicted revenue.
Forecasts to 2025 and other analyses explain and predict the
diabetes treatment market
Why miss crucial data that you need? Why struggle to find
information? Instead our report gives you revenue forecasts to
2025, also with recent results, growth rates, market shares and
discussions.
Our study also shows 90 tables, 91 charts and two interviews. Our
work's purpose is to predict that industry's future, helping your
research, analyses and decisions. See how you can benefit your
reputation for commercial insight, also helping your influence.
Diabetes therapies hold some of the strongest prospects for
pharmaceutical companies. See why and what sales are possible,
finding where money and growth opportunities exist.
Forecasting of the world diabetes drugs market and its segments
– what does the future hold?
What are the secrets of the industry's progress? Where's it
heading? Discover in our report overall world revenue prediction to
2025 for antidiabetic pharmaceuticals, with discussions.
Also find individual revenue forecasts to 2025 for nine
therapeutic submarkets at world level:
- Human insulins and analogues
- Dipeptidyl peptidase-4 inhibitors (DPP-4)
- Biguanides
- Glucagon-like peptide-1 receptor agonists (GLP-1)
- Sulfonylureas.
And these treatment categories:
- Thiazolidinediones
- Alpha-glucosidase inhibitors
- Meglitinides
- Sodium-glucose co-transporter-2 inhibitors (SGLT2)
- Other agents (grouped).
You can assess the outlook for revenue expansion, learning where
you can profit. Find the diabetes market size from 2015-2025. You
can investigate the competition and rising sales. And you will
examine technological, clinical and commercial possibilities.
You will also find top medicines' revenue potentials.
Predictions of leading products' sales – see what's possible,
and where you can gain
How will individual drugs for elevated blood sugar perform to 2025
at world level? Our study forecasts revenues of 31 leading
products. Assess top brands, including these agents:
- Lantus
- Januvia
- NovoLog and NovoMix
- Levemir
- Humalog
- Victoza
- Janumet
- Humulin.
There you will find drugs and the years with highest predicted
sales. You can also examine competitors. So discover what's
happening for lowering blood glucose and controlling its level,
understanding challenges, trends, competition and opportunities for
revenue expansion.
Our work also gives geographical sales predictions.
National markets – what is the outlook for treatment demand and
revenues?
In developed and developing countries, many opportunities for
producers and sellers of diabetes-treating medicines will occur
from 2015 to 2025. See where, how and what's possible.
Our analyses show you individual revenue forecasts to 2025 for
11 national markets:
- United States (US)
- Japan
- EU leaders – Germany,
France, the UK, Italy and Spain (EU5)
- BRIC nations – Brazil,
Russia, India and China.
There you can explore the market progress, needs and opportunities.
What events will change that market and the outlook for payers and
patients? Our work shows you, discussing the trends and
demands.
Events affecting developers, producers and sellers of those
metabolic treatments
Our report also explains issues, forces and events affecting the
antidiabetics industry and market from 2015, including these
influences:
- Drug approvals and R&D in human insulins and analogues, DPP-4
inhibition, GLP-1 therapies, sodium glucose co-transporter
mechanisms and other candidates
- Governmental investment and collaboration between pharmaceutical
companies
- Combination therapies for type 2 diabetes
- Competition from biosimilars and generic drugs – approvals and
product launches.
And these issues are also assessed, among others:
- Disease incidence and prevalence
- Risk factors – obesity and pre-diabetes, related metabolic
conditions
- Drug delivery – technologies for introducing insulin and oral
drugs
- New classes of antidiabetic medications and regulatory
challenges
- Type 1 diabetes vaccine – new treatment approaches, including
disease prevention.
Diabetes management forms a leading use for biological drugs, now
dominant in the pharmaceuticals industry. There you can investigate
what stimulates and restrains that biopharma, affecting its
results. Also you will see the prospects for small-molecule
therapies.
Analysis of firms and potential for rising sales – what overall
revenues are possible?
What happens next? Our study predicts the world market will rise to
$72.6bn in 2019, with high, expanding
revenues from 2015 to 2025. Discover what's possible.
Our analysis covers organisations shaping that industry:
- Novo Nordisk
- Eli Lilly
- Novartis
- AstraZeneca
- Merck & Co.
We also investigate these leading companies, among other firms,
including specialists in metabolic disorders:
- Boehringer Ingelheim
- Takeda
- Sanofi
- Bayer
- Pfizer.
And you will gain interviews with two other authorities on diabetes
treatments. Our survey explores issues affecting that healthcare
industry's present and future.
From 2015, new treatments and demands from patients, doctors and
payers encourage investments, medical advances and higher revenues
from those medications.
Ways Diabetes Drugs: World Industry, Market, R&D and Sales
Forecasts 2015-2025 helps
In particular, our new investigation gives this knowledge to
benefit your work:
- Antidiabetic drug revenues to 2025 at overall world level, for 9
therapeutic submarkets and 31 products – assess outlooks for
production, marketing and sales
- Forecasts to 2025 for 11 national markets in the Americas,
Europe and Asia – investigate developed and developing
countries for demand and revenue potentials
- Prospects for established competitors, rising companies and new
entrants – explore portfolios, opinions, results, strategies,
technologies and outlooks for success
- Review of R&D pipelines – examine progress in research and
development, finding technological and medical prospects
- Analysis of what stimulates and restrains that industry and
market – gauge challenges and strengths, helping you compete, gain
advantages and succeed.
Our new study, produced in-house by our UK-based analysts, helps
your knowledge and authority.
Information found nowhere else, helping your searches,
analyses and plans – and your success
And what is our methodology? We get the most from data,
interpreting its meaning for business now and for the future.
We digest publications and survey authorities, saving you time and
difficulty, helping your planning and decisions. You will hear
what's happening, getting a feel for companies' prospects.
And our study gives independent analysis. There you will receive
competitive intelligence found only in our report, finding where
progress, money and opportunities exist.
Our work assesses diabetes medicines, their producers and
commercial outlooks in detail. That way you find potential gains,
discovering opportunities to harness, as well as benefiting your
influence.
Trying our investigation now lets you see opportunities and revenue
predictions
So with our survey you're less likely to fall behind in knowledge
or miss opportunity. You will find how to save time and effort,
also benefiting your insight, authority and your company's
prospects.
Our new analysis helps professionals like you assess the market for
diabetes treatments. You can explore the trends, discussions and
sales forecasting. Avoid missing out in knowledge. Benefit by
getting our report here now.
Read the full report:
http://www.reportlinker.com/p03083796-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that
finds, filters and organizes the latest industry data so you get
all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/diabetes-drugs-world-industry-market-rd-and-sales-forecasts-2015-2025-300109003.html
SOURCE Reportlinker